Physician profile
David J Finlay
NPI 1245273549
$4,359.69
in general payments reported to CMS, 2019-2025
9 companies · $142 in 2025
The $142 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,284 · 2020: $219 · 2021: $160 · 2022: $1,333 · 2023: $1,078 · 2024: $144 · 2025: $142.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,364.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,364.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,497.06 | 2021-2023 | Endurant Iis, Hawkone, In.Pact Admiral |
| Medtronic Vascular, INC. | $727.32 | 2019-2020 | |
| Silk Road Medical, INC. | $591.43 | 2019-2022 | |
| Cook Medical LLC | $537.16 | 2019-2024 | Zenith Alpha, Zilver Ptx, Cook |
| W. L. Gore & Associates, INC. | $412.94 | 2019-2023 | Gore Viabahn Vbx Balloon Expandable Endo, Gore Tag Conformable Thoracic Endoprosthesis |
| Philips North America LLC | $238.90 | 2019 | |
| Reflow Medical INC | $141.72 | 2025 | |
| Penumbra, INC. | $122.23 | 2024 | Indigo System |
| Abbott Laboratories | $90.93 | 2023 | Diamondback Peripheral |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Finlay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.